- Home
- OVV vs ELAN Comparison
OVV vs ELAN Comparison
Compare OVV & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OVV | ELAN |
|---|---|---|
| Founded | 2020 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 10.3B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | OVV | ELAN |
|---|---|---|
| Price | $42.74 | $24.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 10 |
| Target Price | ★ $49.15 | $24.44 |
| AVG Volume (30 Days) | 3.8M | ★ 4.7M |
| Earning Date | 02-23-2026 | 02-24-2026 |
| Dividend Yield | ★ 2.81% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.90 | 0.07 |
| Revenue | ★ $8,794,000,000.00 | $4,591,000,000.00 |
| Revenue This Year | N/A | $7.25 |
| Revenue Next Year | $0.66 | $5.69 |
| P/E Ratio | ★ $47.49 | $347.70 |
| Revenue Growth | N/A | ★ 3.08 |
| 52 Week Low | $29.80 | $8.02 |
| 52 Week High | $45.96 | $25.29 |
Technical Indicators
Market Signals| Indicator | OVV | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 66.51 | 57.56 |
| Support Level | $40.04 | $24.27 |
| Resistance Level | $42.00 | $25.03 |
| Average True Range (ATR) | 1.25 | 0.69 |
| MACD | 0.39 | -0.00 |
| Stochastic Oscillator | 88.21 | 65.98 |
Price Performance
Historical ComparisonAbout OVV Ovintiv Inc. (DE)
Ovintiv Inc is a North American oil and natural gas exploration and production company that is focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs and natural gas. The company has two operating segments: USA Operations, and Canadian Operations. The USA Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within the United States. The Canadian Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within Canada.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.